By protecting Pyruvate Dehydrogenase Kinase 1 (PDK1) mRNA from degradation caused by YTHDF2, FTO promotes the progression and migration of RCC in an m6A-dependent manner. This evidence concerns the gene FTO and renal cell adenocarcinoma.